Using AI to verify the successful purification and efficient medical activity of lectin from the marine giant kelp Eucheuma serra

Main Article Content

Wei-Yuan Ho Chien Hua Liao Hsing-Chung Chen

Abstract

The purpose of this study is to apply artificial intelligence (AI) technology to establish a model system that can effectively verify the purification success rate and medicinal activity potential of the marine giant alga Eucheuma serra lectin. Lectins are a class of proteins with sugar recognition capabilities that are widely found in seaweed. The large red algae in this study showed great potential in biomedical applications such as anti-tumor, anti-viral and immune regulation. The author's research on the purification and functional verification of lectins often consumes a lot of manpower and time, and its success rate is also affected by a variety of physical and chemical factors. This research paper shows through laboratory experiments that red algae has strong agglutination ability. The activity of seaweed extract will decrease after being stored at 4℃ or -20℃ for half a year. Taking Eucheuma as an example, the best time for enzymes to work is 2 to 6 hours. Although it is not a high temperature resistant variety, it can still maintain its original activity at 55℃. The ESA separated and purified by DEAE column contained 10.2 mg protein per 1 g dry weight. The molecular weight of the obtained algae lectin was determined to be 29000 by SDS-PAGE gel electrophoresis. The results of sugar inhibition assay showed that this lectin has affinity for a variety of monosaccharides and oligosaccharides. In terms of screening anti-cancer components from Eucheuma serrulata lectin, anti-cancer components were also discovered in the lectin of the large alga Eucheuma serrulata using AI methods. This study used the random forest algorithm as a validation object and combined it with more than 350 red algae protein information collected from public databases (such as Kaggle, UniProt, PDB, etc.) for feature modeling. After feature selection and model training, this AI model showed excellent performance on the test data set (average accuracy reached 86.3%, and F1-score and recall rate both reached above 0.84). Feature importance analysis indicated that it has a highly stable β-folded structure, which helps to maintain high activity under human physiological conditions. High hydrophilicity in terms of isoelectric point (acidic pI value, using neutral buffer) and hydrophobicity index is beneficial to maintaining solubility and structural stability. After purification under specific conditions, Eucheuma lectin has unlimited application potential in traditional Chinese and Western medicine, which will help to quickly screen lead compounds and develop high-efficiency natural medicine sources in the future. This cross-domain application also demonstrates the high value of AI technology in the fields of marine biological resource development, functional proteins and biomedical engineering, and lays a technical foundation for the transformation research of natural algae into medicines. Especially in medicine, it has high anti-tumor and anti-viral activity, and is very worthy of large-scale production and various applications.

Keywords: artificial intelligence (AI), lectin, Eucheuma serra, purification prediction, random forest, biological activity, natural product medicine source

Article Details

How to Cite
HO, Wei-Yuan; LIAO, Chien Hua; CHEN, Hsing-Chung. Using AI to verify the successful purification and efficient medical activity of lectin from the marine giant kelp Eucheuma serra. Medical Research Archives, [S.l.], v. 13, n. 6, june 2025. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/6595>. Date accessed: 17 july 2025. doi: https://doi.org/10.18103/mra.v13i6.6595.
Section
Research Articles

References

1. Liao WR. The Newly Organized Biology. Yung-Ta Publishing House; 2002.

2. Hsieh MC. Blue-Green Algae Health Revolution. Shih-Mao Publishing House; 1998.

3. Liao WR. The Microbiology Experiment. Yung-Ta Publishing House; 2002.

4. Liao WR, Ling JY, Shieh WY, Jeng WL, Huang R. Antibiotic activity of lectins from marine algae against marine vibrios. J Ind Microbiol Biotechnol. 2003;30:1-16.

5. Li IH. The Book on Chinese Medicine: Preparation and Application. Ming ShiH Publishing Co, Ltd.; 2003.

6. Liao WR, Shieh WY, Jeng WL, Ling JY, Huang R. Antibiotic activity of lectins from marine algae against marine vibrios. J Ind Microbiol Biotechnol. 2002;24:262-266.

7. Liao WR. Nanotechnology and Life. Wune Books; 2007.

8. Unknown. In vitro and toxicological assessment of dexamethasone sodium phosphate loaded pH sensitive Pectin-g-poly(AA)/PVP semi interpenetrating network. Mater Today Commun. 2020.

9. Akihiro K, Hiroyuki M, Jun-ichi O, Hideo H, Kanji H. Occurrence of highly yielded lectins homologous within the genus Eucheuma. J Appl Phycol. 1999; 11:149-156.

10. Akihiro K, Hiroyuki M, Jun-ichi O, Hideo H, Kanji H. The marine red alga Eucheuma serra J. Agardh, a high yielding source of two isolectins. J Appl Phycol. 1997;9:331-338.

11. Bird KT, Chiles TC, Longley RE, Kendrick AF, Kinkema MD. Agglutinins from marine macroalgae of the southeastern United States. J Appl Phycol. 1993;5:2134-218.

12. Bernheimer A. Hemagglutinin in caterpillar bloods. Science. 1952;115:150-152.

13. Blunden G, Roger DJ, Farnham WF. Survey of British seaweeds for haemagglutinins. Lloydia. 1975;38:162-168.

14. Boyd WC. Hemagglutinating substances of human cells in various Egyptian plants. J Immunol. 1950;65:281.

15. Boyd WC, Reguera RM. Hemagglutinating substances for human cells in various plants. J Immunol. 1949;62:333.

16. Boyd WC, Brown R. A specific agglutinin in the snail, Otala lactea. Nature. 1965;280:584-593.

17. Boyd WC, Almodovar LR, Boyd LG. Agglutinins in marine algae for human erythrocytes. Transfusion. 1966;6:82-83.

18. Bolwell GP, Callow JA, Callow ME, Evans LV. Cross-fertilisation in fucoid seaweeds. Nature. 1977;268:626-627.

19. Brain KR, Chalopin MC, Tumer TD, Blunden G, Wildgoose PB. Cytokinin activity of commercial aqueous extract. Plant Sci Lett. 1973;1:241-245.

20. Cushing JE. Individual variation in the hemagglutinin content of yellowfin tuna and skipjack bloods. J Immunol. 1953;68:543.

21. Chiles TC, Bird KT. A comparative study of animal erythrocyte agglutinins from marine algae. Comp Biochem Physiol B. 1989;94(2):107-111.

22. Coats DW, Tyler MA, Anderson DM. Sexual processes in the life cycle of Gyrodinium uncatenum (Dinophyceae). J Phycol. 1984;20:351-361.

23. Crouch IJ, Van Staden J. Evidence for the presence of plant growth regulators. Plant Growth Regul. 1993;13:21-29.

24. Deasi P, Springer G. Eel serum anti-human blood group H(O) protein. Methods Enzymol. 1972; 28:383-388.

25. Den H, Malinzak D. Isolation and properties of β-galactoside specific lectin from chicle embryo thigh muscle. J Biol Chem. 1977;252:5444-5448.

26. Etzler ME. Distribution and function of plant lectins. In: Liener IE, Sharon N, Goldstein IJ, eds. The Lectins. Academic Press; 1986:371-435.

27. Estola E, Ovatia O. Phytohemagglutinins in lichens. Ann Med Exp Biol Fenn. 1955;33:392-395.

28. Fabregas J, Munoz A, Llovo J, Abalde J. Agglutinins in marine red algae. IRCS Med Sci. 1984;12:298-299.

29. Ferreiros CM, Criado MT. Purification and partial characterization of a Fucus vesiculosus agglutinin. Rev Esp Fisiol. 1983;39:51-60.

30. Fabregas J, Llovo J, Munoz A. Hemagglutinins in red seaweeds. Bot Mar. 1983;28:517-520.

31. Ford WW. The distribution of haemolysins, agglutinins, and poisons in fungi. J Pharmacol Exp Ther. 1911;2:285-318.

32. Featonby-Smith BC, Van Staden J. Identification and seasonal variation of endogenous cytokinins in Ecklonia maxima (Osbeck) Papenf. Bot Mar. 1984; 27:527-531.

33. Chen C, Zhang Y, Yu X, Liu Y. Application of machine learning algorithms in prediction of protein-ligand interactions. Artif Intell Life Sci. 2021;1(1):100003. doi:10.1016/j.ailsci.2021.100003

34. Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583-589. doi:10.1038/s41586-021-03819-2

35. Misra D, Saha S, Das S. Protein purification success prediction using ensemble machine learning models. Comput Biol Chem. 2019;79:102-110. doi:10.1016/j.compbiolchem.2019.01.004

36. Sato Y, Hirayama M, Yamada Y, Takahashi H, Nakamura-Tsuruta S. Marine algal lectins and their potential in biomedical and pharmaceutical applications. Mar Drugs. 2019;17(5):289. doi:10.33 90/md17050289

37. Senior AW, Evans R, Jumper J, et al. Improved protein structure prediction using potentials from deep learning. Nature. 2020;577(7792):706-710. doi:10.1038/s41586-019-1923-7

38. Sharon N, Lis H. History of lectins: From hemagglutinins to biological recognition molecules. Glycobiology. 2004;14(11):53R-62R. doi:10.1093/g lycob/cwh122

39. Shiomi K, Sato Y, Tateno H, Hirayama M. Lectins from marine organisms: Diversity, physiological roles and biomedical applications. In: Adv Exp Med Biol. 2013;842:165-182. doi:10.1007/978-1-4939-0787-9_10

40. UniProt Consortium. UniProt: The universal protein knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523-D531. doi:10.1093/nar/gkac1052

41. Wang Q, Liu X, Liu Z, Zhang X. Lectins from red algae: Diversity, structure and biomedical applications. Int J Biol Macromol. 2020;165:985-995. doi:10.1016/j.ijbiomac.2020.09.131

42. Zhang W, Sun X, Zhang Y, Chen H. Red algal lectins: Structures, interactions and therapeutic potential. Mar Drugs. 2018;16(11):400. doi:10.339 0/md16110400

43. Chen Y, Li Z, Wang H, Xu Q. Predictive modeling in protein purification using random forest algorithm. J Proteome Res. 2021;20(3):1256-1264. doi:10.1021/acs.jproteome.0c00845

44. Misra A, Ghosh S, Chatterjee D. Machine learning in biotechnology: Advances and applications. Biochem Eng J. 2019;148:59-71. doi:10.1016/j.bej.2 019.05.007